OBD

Oxford BioDynamics

Cancer Biomarkers: the Liquid Biopsy Revolution

Biomarkers  are measurable biological entities which hold the key to precision medicine. In the cancer arena, people are looking for biomarkers to detect the disease early, monitor therapeutic efficacy, and

Oxford BioDynamics

Epigenetic biomarkers predict immunotherapy success

UK biotech Oxford BioDynamics has presented data showing that the company’s blood test can predict patient response to treatment with immune checkpoint inhibitors anti-PD-1 and anti-PD-L1. At the ASH Summit